Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 18/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23117618 | 0.96 | MEN1 (0.49) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL34597 | 0.95 | FDPS (0.45) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL31167993 | 0.94 | MEN1 (0.56) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL34146 | 0.94 | MEN1 (0.51) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL14644851 | 0.93 | MEN1 (0.53) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL13161377 | 0.93 | MEN1 (0.49) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL13866471 | 0.93 | FDPS (0.43) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL31397556 | 0.92 | FDPS (0.44) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| SCHEMBL34726 | 0.91 | FDPS (0.46) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS | |
| Trifluoromethanesulfonic Acid SCHEMBL34575 | 0.90 | FDPS (0.44) | MEN1HSP90AA1KMT2ASMN1; SMN2FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130039-A1 | LOW-VOLTAGE ORGANIC LIGHT-EMITTING SYNAPSE ELEMENT AND STIMULUS-SENSITIVE NEUROMORPHIC DISPLAY DEVICE COMPRISING SAME | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2026-05-07 | — | — | US | disclosed |
| CN-118843914-A | Solid electrolytic capacitor and method for manufacturing the same | 佳里多股份公司 | 2024-10-25 | — | — | CN | disclosed |
| US-20240350800-A1 | LOW-POWER STRETCHABLE NEUROMORPHIC NERVE DEVICE WITH PROPRIOCEPTIVE FEEDBACK | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-10-24 | — | — | US | disclosed |
| WO-2024219557-A1 | LOW-POWER STRETCHABLE NEUROMORPHIC NERVE DEVICE WITH PROPRIOCEPTIVE FEEDBACK | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2024-10-24 | — | — | WO | disclosed |
| WO-2024167347-A1 | STRETCHABLE ELECTRODE, STRETCHABLE ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND METHOD FOR MANUFACTURING SAME | 서울대학교산학협력단 | 2024-08-15 | — | — | WO | disclosed |
| WO-2023224434-A1 | LOW-VOLTAGE ORGANIC LIGHT-EMITTING SYNAPSE ELEMENT AND STIMULUS-SENSITIVE NEUROMORPHIC DISPLAY DEVICE COMPRISING SAME | 서울대학교산학협력단 | 2023-11-23 | — | — | WO | disclosed |
| CN-110559435-A | Liquid protein formulations comprising ionic liquids | 伊戈尔生物药品股份有限公司 | 2019-12-13 | — | — | CN | disclosed |
| EP-2473277-B1 | PALLADIUM CATALYST SYSTEM COMPRISING ZWITTERION OR ACID-FUNCTIONALIZED IONIC LIQUID | UNIV DENMARK TECH DTU (DK) | 2019-07-03 | — | — | EP | disclosed |
| US-20170341067-A1 | Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid | UNIV DENMARK TECH DTU (DK) | 2017-11-30 | — | — | US | disclosed |
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | UNIVERSITE DE MONTREAL (CA) | 2012-09-13 | — | — | US | disclosed |
| US-7687212-B2 | Charge trapping releaser containing photogenerating layer photoconductors | XEROX CORPORATION (US) | 2010-03-30 | — | — | US | disclosed |
| US-20090292105-A1 | SULPHONYL-1,2,4-TRIAZOLE SALTS | PHOSTECH LITHIUM INC. (CA) | 2009-11-26 | — | — | US | disclosed |
| US-20090092913-A1 | ADDITIVE CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092915-A1 | PHOSPHONIUM CONTAINING CHARGE TRANSPORT LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092914-A1 | PHOSPHONIUM CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092909-A1 | CHARGE TRAPPING RELEASER CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092912-A1 | IMIDAZOLIUM SALT CONTAINING CHARGE TRANSPORT LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20090092911-A1 | ADDITIVE CONTAINING CHARGE TRANSPORT LAYER PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-04-09 | — | — | US | disclosed |
| US-20070231647-A1 | Proton Conductor and Fuel Cell Using the Same | NISSAN MOTOR CO., LTD. | 2007-10-04 | — | — | US | disclosed |
| EP-1796193-A1 | PROTON CONDUCTOR AND FUEL CELL USING THE SAME | Nissan Motor Co., Ltd. (JP) | 2007-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292105-A1 | SULPHONYL-1,2,4-TRIAZOLE SALTS | TST, STS, SQOR | MEN1 4248/4885HSP90AA1 4151/4885KMT2A 1136/4885 |
| US-20120232285-A1 | Sulfonyl-1,2,4-triazole salts | STS, TST, FIS1 | MEN1 3659/4885HSP90AA1 4410/4885KMT2A 1548/4885 |
| US-20260130039-A1 | LOW-VOLTAGE ORGANIC LIGHT-EMITTING SYNAPSE ELEMENT AND STIMULUS-SENSITIVE NEUROMORPHIC DISPLAY DEVICE COMPRISING SAME | L1CAM, HCN3, NCS1 | MEN1 91/4885HSP90AA1 4212/4885KMT2A 1899/4885 |
| US-20070231647-A1 | Proton Conductor and Fuel Cell Using the Same | SLC9A2, SLC9A1, SLC9A3 | MEN1 552/4885HSP90AA1 1748/4885KMT2A 1938/4885 |
| US-20170341067-A1 | Palladium Catalyst System Comprising Zwitterion And/Or Acid-Functionalyzed Ionic Liquid | PDCD2L, PCCA, PDK2 | MEN1 1283/4885HSP90AA1 4752/4885KMT2A 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.